Ken Griffin Acrivon Therapeutics, Inc. Transaction History
Citadel Advisors LLC
- $509 Billion
- Q1 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 1,680,027 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,680,027
Previous 1,649,659
1.84%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ACRV
# of Institutions
46Shares Held
10.7MCall Options Held
0Put Options Held
0-
Perceptive Advisors LLC New York, NY3.01MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA1.65MShares$00.0% of portfolio
-
Wellington Management Group LLP Boston, MA888KShares$00.0% of portfolio
-
Black Rock Inc. New York, NY744KShares$00.0% of portfolio
-
Marshall Wace, LLP London, X0597KShares$00.0% of portfolio